CryoPort (NASDAQ:CYRX) Issues Quarterly Earnings Results

CryoPort (NASDAQ:CYRX) announced its quarterly earnings results on Tuesday, March 6th. The consumer goods maker reported ($0.09) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.02), Bloomberg Earnings reports. CryoPort had a negative net margin of 66.09% and a negative return on equity of 47.36%. The business had revenue of $3.33 million during the quarter, compared to the consensus estimate of $3.37 million. The firm’s revenue for the quarter was up 49.5% on a year-over-year basis.

Shares of CryoPort (NASDAQ:CYRX) traded down $0.50 during midday trading on Wednesday, reaching $9.58. 128,552 shares of the company’s stock traded hands, compared to its average volume of 122,275. The company has a market capitalization of $268.75, a P/E ratio of -27.37 and a beta of 0.71. CryoPort has a twelve month low of $1.96 and a twelve month high of $10.40.

An institutional investor recently raised its position in CryoPort stock. Northern Trust Corp boosted its position in CryoPort Inc (NASDAQ:CYRX) by 105.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,179 shares of the consumer goods maker’s stock after purchasing an additional 11,358 shares during the period. Northern Trust Corp owned approximately 0.09% of CryoPort worth $109,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 22.83% of the stock is currently owned by institutional investors and hedge funds.

A number of brokerages recently commented on CYRX. Needham & Company LLC reaffirmed a “buy” rating and issued a $11.00 price target (up previously from $10.00) on shares of CryoPort in a report on Thursday, March 8th. Roth Capital assumed coverage on shares of CryoPort in a report on Thursday, November 30th. They issued a “buy” rating and a $12.50 price target for the company. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $33.70.

TRADEMARK VIOLATION NOTICE: This report was posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this report on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this report can be viewed at

CryoPort Company Profile

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Earnings History for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with's FREE daily email newsletter.

Leave a Reply